Enliven Therapeutics Inc — Cash Flow (NASDAQ:ELVN) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Cash from operating activities 37.4 M46.77 M35.57 M61.27 M73.19 M 71.67 M Cash from investing activities 16.72 M1.63 M76.52 M148.41 M36 M 185.49 M Cash from financing activities 96.88 M49.1 M1.23 M234.29 M133.16 M 258.22 M Free cash flow 37.38 M46.76 M35.2 M61.12 M73.15 M 71.51 M

新闻

Enliven Therapeutics董事Heyman出售3.2万美元股票

Heyman, Enliven Therapeutics director, sells $32k in stock

Lyssikatos，Enliven Therapeutics首席科学官出售价值14.5万美元股票

Lyssikatos, Enliven Therapeutics CSO, sells $145k in shares

Lyssikatos, Enliven Therapeutics CSO, sells $535k in ELVN stock

Enliven Therapeutics董事Heyman出售价值32,901美元的股票

Enliven Therapeutics director Heyman sells $32,901 in stock

Enliven Therapeutics首席运营官Anish Patel出售价值135万美元ELVN股票

Anish Patel, COO of Enliven Therapeutics, sells $1.35m in ELVN

Enliven Therapeutics: Springing Into 2026 With Data, But I'm Still Cautious

Enliven Therapeutics首席科学官Lyssikatos出售价值347万美元股票

Enliven Therapeutics CSO Lyssikatos sells $3.47 million in shares